Brief: Solara Active Pharma Sciences Says Got Zero 483s Post USFDA Inspection At Ambernath Facility
28/01/2019 05:22
Jan 28 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* SAYS SOLARA COMPLETES USFDA INSPECTION WITH ZERO 483S
* USFDA INSPECTION OF ITS MANUFACTURING FACILITY IN
AMBERNATH,
MAHARASHTRA
Source text: http://bit.ly/2RXYanm
Further company coverage: SOLA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees